Cullinan Oncology, Inc. (CGEM) DCF Valuation

Cullinan Oncology, Inc. (CGEM) Valoración de DCF

US | Healthcare | Biotechnology | NASDAQ
Cullinan Oncology, Inc. (CGEM) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Cullinan Oncology, Inc. (CGEM) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Descubra el verdadero valor de Cullinan Oncology, Inc. (CGEM) con nuestra calculadora DCF avanzada! Ajuste los supuestos esenciales, explore varios escenarios y evalúe cómo los diferentes factores afectan la valoración de la oncología de Cullinan, todo dentro de una sola plantilla de Excel.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 18.9 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 -100 0 -25 -25 -25 -25 -25
EBITDA -22.2 -60.3 -67.9 151.4 -190.3 .0 .0 .0 .0 .0
EBITDA, % 100 100 -358.45 100 100 60 60 60 60 60
Depreciation .1 .1 .1 .1 .3 .0 .0 .0 .0 .0
Depreciation, % 100 100 0.27979 100 100 80.06 80.06 80.06 80.06 80.06
EBIT -22.3 -60.3 -68.0 151.3 -190.6 .0 .0 .0 .0 .0
EBIT, % 100 100 -358.73 100 100 60 60 60 60 60
Total Cash 98.6 210.2 430.9 550.1 467.1 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 0 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 0 100 100 80 80 80 80 80
Accounts Payable .9 9.7 3.2 2.7 2.5 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 16.73 100 100 83.35 83.35 83.35 83.35 83.35
Capital Expenditure .0 .0 -.6 -1.1 -.2 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 -3.11 100 100 -0.6221 -0.6221 -0.6221 -0.6221 -0.6221
Tax Rate, % 9.49 9.49 9.49 9.49 9.49 9.49 9.49 9.49 9.49 9.49
EBITAT -20.6 -51.6 -65.5 111.2 -172.6 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -19.6 -42.8 -72.5 109.7 -172.6 -2.5 .0 .0 .0 .0
WACC, % 5.38 5.38 5.39 5.38 5.38 5.38 5.38 5.38 5.38 5.38
PV UFCF
SUM PV UFCF -2.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt -95
Equity Value 92
Diluted Shares Outstanding, MM 42
Equity Value Per Share 2.23

What You Will Receive

  • Pre-Loaded Financial Model: Cullinan Oncology's actual data provides accurate DCF valuation.
  • Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other essential drivers.
  • Real-Time Calculations: Automatic updates allow you to view results instantly as you make adjustments.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
  • Flexible and Reusable: Designed for adaptability, enabling repeated use for in-depth forecasts.

Key Features

  • Comprehensive Financial Data: Gain access to reliable pre-loaded historical figures and future forecasts for Cullinan Oncology, Inc. (CGEM).
  • Adjustable Forecast Parameters: Modify yellow-highlighted fields such as WACC, growth rates, and profit margins to suit your analysis.
  • Real-Time Calculations: Enjoy automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
  • User-Friendly Dashboard: Intuitive charts and summaries that make it easy to interpret your valuation outcomes.
  • Designed for All Users: A straightforward, user-friendly layout tailored for investors, CFOs, and consultants alike.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based CGEM DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
  3. Instant Calculations: The model automatically recalculates Cullinan Oncology’s intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
  5. Analyze and Decide: Leverage the results to inform your investment or financial analysis.

Why Choose This Calculator for Cullinan Oncology, Inc. (CGEM)?

  • Comprehensive Tool: Integrates DCF, WACC, and financial ratio analyses tailored for CGEM.
  • Customizable Inputs: Modify yellow-highlighted cells to explore different investment scenarios.
  • Detailed Insights: Automatically computes Cullinan Oncology’s intrinsic value and Net Present Value.
  • Preloaded Data: Historical and projected data provide a solid foundation for analysis.
  • Professional Quality: Perfect for financial analysts, investors, and business consultants focused on CGEM.

Who Should Use This Product?

  • Investors: Accurately assess Cullinan Oncology’s fair value before making investment choices.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to CGEM.
  • Consultants: Efficiently modify the template for valuation reports tailored to clients in the biotech sector.
  • Entrepreneurs: Acquire insights into financial modeling practices employed by leading pharmaceutical companies.
  • Educators: Implement it as a teaching resource to illustrate valuation techniques in the healthcare industry.

What the Template Contains

  • Historical Data: Includes Cullinan Oncology’s past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Cullinan Oncology’s intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Cullinan Oncology’s financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.